NCT06064058

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain in Prediabetic Non-obese Patients: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: University of Baghdad · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

Prediabetes, characterized by elevated HbA1c levels, is a common precursor to type 2 diabetes mellitus. Recent studies have suggested a potential link between prediabetes and nonspecific back pain. This randomized controlled trial aimed to assess whether reducing HbA1c levels through lifestyle interventions and, along with the correction of vitamin D and magnesium, can alleviate nonspecific back pain in prediabetic patients.

Detailed description

The study included 40 patients from an outpatient clinic in Baghdad, evenly divided into intervention and control groups. The intervention group underwent a 6-month lifestyle modification program, focusing on diet, sleep, exercise, and vitamin D and magnesium correction. HbA1c levels were measured, and back pain severity was assessed (through what assessment method ?). The control group received standard care with NSAIDs and acetaminophen for pain management. Assessments were conducted at baseline and at various intervals over a total period of 6 months to evaluate changes in HbA1c levels and back pain intensity. This randomized controlled trial provides evidence that reducing HbA1c levels through lifestyle modifications, along with the correction of vitamin D and magnesium, can lead to a reduction in nonspecific back pain intensity and improved functional outcomes in prediabetic patients.

Conditions

• Back Pain Lower Back Chronic
• Back Pain
• Pre Diabetes
• Diabetes
• Back Pain, Low

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Ghazwan program	6-month lifestyle modification program, focusing on diet, sleep, exercise, and vitamin D and magnesium correction.
DRUG	Standard management	Standard care with NSAIDs and acetaminophen for pain management

Timeline

• Start date: 2023-01-30
• Primary completion: 2023-08-30
• Completion: 2023-09-01
• First posted: 2023-10-03
• Last updated: 2023-10-05

Locations

1 site across 1 country: Iraq